B7-H3.CD28Z.CART in CNS Neoplasms | MicrobiomeTrials← Back to trialsNCT07390539
B7-H3.CD28Z.CART in CNS Neoplasms
RecruitingPHASE1INTERVENTIONAL
Trial Details
Start: 2026-09Est. Completion: 2030-08-31
Enrollment target: 70 participants Locations- Boston Children's Hospital, Boston, Massachusetts, United States
- Dana-Farber Cancer Institute, Boston, Massachusetts, United States
Other microbiome trials you might be interested in
Rare DiseasesGeneralized Myasthenia Gravis (gMG)
This is a multicenter, non-interventional, retrospective-prospective, single-arm observational study designed to describ…
Kazan', RussiaEst. completion Dec 31, 2029
Acute Flaccid ParalysisAFPGullian Barre SyndromeTransverse Myelitis
This study is observational study aims to study the Clinical profile, Possible risk factors and Outcome of Acute flaccid…
Sohag, EgyptEst. completion Sep 1, 2027
Systemic Lupus Erythematosus (SLE)
In this study, researchers will learn more about a study drug called litifilimab (BIIB059) in participants with systemic…
Phoenix, United StatesCompleted Mar 29, 2030